Management Team

Mark Pinder

Chief Executive Officer

As CEO, Mark is responsible for managing the company’s direction, innovation, investment and sales strategy. Mark has been a senior executive in several leading advertising and brand marketing companies, including Lowey International and McCann-Erickson. He also worked for many years as a consultant to the UKTI and Foreign & Commonwealth Office. Mark is the inventor of Trecento’s HygieCatch and is a serial inventor and entrepreneur having built and sold several successful businesses and consumer healthcare brands.

Chris Sessions

Chief Operating Officer

As COO, Chris has responsibility for the day-to-day running of the company and its product development, production and distribution facilities. Chris has been a senior executive of several well-known marketing companies and has provided niche strategic consultancy to the international healthcare industry. Chris has also developed several well-known consumer healthcare product brands and is one of the UK’s leading authorities on consumer retail healthcare and over-the-counter testing.

Dr Stuart Wilson

Chief Scientific Adviser

Stuart is a molecular biologist. He started his career in academia as Senior Lecturer at the internationally renowned London School of Hygiene & Tropical Medicine and then moved into public health as Deputy Director of the National TB Reference Laboratory, where he set up and managed the molecular diagnostic service. More recently, he has been founder and CSO of a number of companies that have successfully launched innovative products and received substantial royalty income from technology licensing.

Jeff Jeffries

Interim Chief Financial Officer

Formerly a Partner with Top 10 accountancy firms BDO and PKF, Jeff has over 30 years’ experience working with growing and aspirational companies providing assurance, advisory and corporate finance services. He has advised on a wide range of transactions including fund raising, buying and selling businesses, deal structuring and reorganisations. Jeff left BDO to establish his own niche accountancy practice and joined Trecento Diagnostics Limited in 2019 to provide board support during a funding round and to oversee the financial reporting during a period of transition and growth in 2019 and 2020.

Karl Wills

Non-Executive Director

Karl is a successful serial inventor and entrepreneur who has built and sold a number of highly innovative businesses including Pelipod (sold to BT), MetaPack (sold to and Abacus (sold to MindCTI) and has invented and brought to market a number of products and information systems. Karl co-founded Trowlock Strategic Planning, providing funding, knowledge and experience to accelerate technology-based SME’s through scale-up to growth.

Peter O’Hara

Non-Executive Director

Peter is passionate about investing in people and is one of the UK’s leading innovators and entrepreneurs, best known for building from scratch several highly successful computer software companies including OLM Group which today employs over 300 people. Peter has played an important role in transforming and improving social and healthcare across the UK.